Investigators at Amiens University Detail Findings in Chronic Kidney Disease [Drugs With a Negative Impact On Cognitive Function (Part 1): Chronic Kidney Disease As a Risk Factor].

Amiens, France, Europe, Adverse Drug Reactions, Central Nervous System, Chronic Kidney Disease, Drugs and Therapies, Health and Medicine, Kidney Diseases and Conditions, Polypharmacy, Risk and Prevention Along with CKD progression, the accumulation of uremic toxins may lead to blood-brain barrier (BBB) disruption and pharmacokinetic alterations, increasing the risk of adverse reactions affecting the central nervous system (CNS). Keywords: Amiens; France; Europe; Adverse Drug Reactions; Central Nervous System; Chronic Kidney Disease; Drugs and Therapies; Health and Medicine; Kidney Diseases and Conditions; Polypharmacy; Risk and Prevention EN Amiens France Europe Adverse Drug Reactions Central Nervous System Chronic Kidney Disease Drugs and Therapies Health and Medicine Kidney Diseases and Conditions Polypharmacy Risk and Prevention 1298 1298 1 11/06/23 20231110 NES 231110 2023 NOV 10 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on Kidney Diseases and Conditions - Chronic Kidney Disease have been published. [Extracted from the article]